Australaw Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2014-01-30 and was issued with the 167783708 ACN. Its Australian Business Number is 15167783708. Since 2019-10-31, the company is headquartered in NSW, post code 2303. The previous headquarters were located in NSW 2302 (from 2014-09-24 to 2019-10-31), NSW 2302 (from 2014-01-30 to 2014-09-24). Australaw Pty Ltd was registered for the GST on 2014-01-30. The company has also used 2 business names, namely Australaw from 2016-11-11, Kelso Lawyers from 2014-02-11. The above data comes from the ABN database which was updated on 2019-10-31.
Status | From | To |
---|---|---|
Active | 2014/01/30 | current |
Name | From | To |
---|---|---|
Australaw Pty Ltd | 2014/01/30 | current |
Name | From | To |
---|---|---|
Australaw | 2016/11/11 | current |
Kelso Lawyers | 2014/02/11 | current |
Location | From | To |
---|---|---|
NSW 2303 | 2019/10/31 | current |
NSW 2302 | 2014/09/24 | 2019/10/31 |
NSW 2302 | 2014/01/30 | 2014/09/24 |
Status | From | To |
---|---|---|
Registered | 2014/01/30 | current |
Advertisements
Status | registered |
Registration date | 2014/02/11 |
Renewal date | 2018/02/11 |
Address for service of documents | PO BOX 2293 Dangar NSW 2309 Australia |
Principal place of business | 671-677 Hunter St Newcastle West NSW 2302 |
Debtor representative | not applicable |
Notified successor | not applicable |
Advertisements
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.